Fallopian tube cytology combined with p53 and PAX-8 immunocytochemistry in diagnosing ovarian carcinoma: a prospective study.
6 affiliations
- 1Department of Gynaecological Oncology, Metaxa Memorial Cancer Hospital, Mpotasi 51, Piraeus, Athens, 18537, Greece. [email protected].
- 2Department of Gynaecological Oncology, Metaxa Memorial Cancer Hospital, Mpotasi 51, Piraeus, Athens, 18537, Greece.
- 3Second Department of Obstetrics and Gynecology, National Kapodistrian University of Athens, Aretaieio Hospital, Athens, Greece.
- 4Cytopathology Department, Metaxa Memorial Cancer Hospital of Piraeus, Piraeus, Greece.
- 5Department of Pathology, Metaxa Memorial Cancer Hospital, Piraeus, Greece.
- 6Second Department of Pathology, Attikon University Hospital, Athens, Greece.
Abstract
Objective
Ovarian cancer has a high mortality rate, primarily due to delayed diagnosis caused by the lack of effective diagnostic tools. Based on the tubal origin of extra-uterine high grade serous carcinomas, we aimed to evaluate the diagnostic accuracy of cytological examination of ex vivo fallopian tube brushings, alone and in combination with p53 and PAX-8 immunocytochemistry, for the identification of ovarian carcinoma, with a particular focus on high-grade serous carcinoma (HGSC).Methods
Our study included patients who underwent pelvic surgery for any adnexal pathology. Ex vivo, fallopian tube smears were collected using a soft brush and placed on both microscopic slides and in Thin Prep solution. The cytological samples were classified as benign, atypical or malignant, followed by immunocytochemical evaluation for p53 protein and PAX-8. The SEE-Fim protocol was used for tubal histopathological assessment.Results
Out of 103 evaluable cases, pathology identified 12 borderline tumors, 44 benign cases and 47 malignant ones, including 28 high-grade serous carcinoma cases. Cytology alone demonstrated an overall accuracy of 71.88%, while p53 showed an accuracy of 73.79% and PAX-8 an accuracy of 69.90%. After combining all three methods through logistic regression analysis, specificity increased to 83.93%, positive predictive value to 78.05%, and overall accuracy to 76.60%. Following a sub-analysis focusing on high-grade serous carcinoma, cytology reached a sensitivity of 92.86%, while p53 and PAX-8 reached 82.14% and 78.57% respectively. The combination of cytology with PAX-8 further increased sensitivity to 100%.Conclusions
The combination of tubal cytology and immunocytochemistry could be used as a reliable diagnostic tool for extrauterine high-grade serous carcinoma. Further evaluation of a larger sample size is warranted.
Related
- Diagnostic Challenge in Cytology: Fibrosing Thyroiditis Mimicking Medullary Thyroid Carcinoma.
- Unexpected Pericardial Cytology in a Patient With Primary Squamous Cell Carcinoma of the Lung: Emphasizing the Need for Advanced Molecular Characterization of Tumors
- Developing an automated cytology-based DNA ploidy test for detecting oral squamous cell carcinoma in Taiwan: A feasibility study.
- Performance of ultra-sensitive electrochemiluminescence LAM assay for diagnosing tuberculosis in HIV-negative individuals: a multicentre, prospective diagnostic study
- Ultrasonography (IOTA‐ADNEX) vs magnetic resonance imaging (ADNEX MR) for diagnosing ovarian cancer in high‐risk patients: a prospective study
BibTeX
@article{lekka2026fallopian,
title = {{Fallopian tube cytology combined with p53 and PAX-8 immunocytochemistry in diagnosing ovarian carcinoma: a prospective study.}},
author = {Sofia Lekka and Victoria Psomiadou and Theodoros Panoskaltsis and Eleni Tsouma and Olympia Tzaida and Helen Trihia and Abraham Pouliakis and Dimitrios Korfias and Panagiotis Giannakas and Panagiotis Vakas and Nikolaos Vlahos and George Vorgias},
journal = {BMC cancer},
year = {2026},
month = aug,
doi = {10.1186/s12885-026-16649-0},
url = {https://europepmc.org/article/MED/42968063},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Fallopian tube cytology combined with p53 and PAX-8 immunocytochemistry in diagnosing ovarian carcinoma: a prospective study.
AU - Sofia Lekka
AU - Victoria Psomiadou
AU - Theodoros Panoskaltsis
AU - Eleni Tsouma
AU - Olympia Tzaida
AU - Helen Trihia
AU - Abraham Pouliakis
AU - Dimitrios Korfias
AU - Panagiotis Giannakas
AU - Panagiotis Vakas
AU - Nikolaos Vlahos
AU - George Vorgias
PY - 2026
DA - 2026/08/01
JO - BMC cancer
DO - 10.1186/s12885-026-16649-0
UR - https://europepmc.org/article/MED/42968063
AB - Objective Ovarian cancer has a high mortality rate, primarily due to delayed diagnosis caused by the lack of effective diagnostic tools. Based on the tubal origin of extra-uterine high grade serous carcinomas, we aimed to evaluate the diagnostic accuracy of cytological examination of ex vivo fallopian tube brushings, alone and in combination with p53 and PAX-8 immunocytochemistry, for the identification of ovarian carcinoma, with a particular focus on high-grade serous carcinoma (HGSC).Methods Our study included patients who underwent pelvic surgery for any adnexal pathology. Ex vivo, fallopian tube smears were collected using a soft brush and placed on both microscopic slides and in Thin Prep solution. The cytological samples were classified as benign, atypical or malignant, followed by immunocytochemical evaluation for p53 protein and PAX-8. The SEE-Fim protocol was used for tubal histopathological assessment.Results Out of 103 evaluable cases, pathology identified 12 borderline tumors, 44 benign cases and 47 malignant ones, including 28 high-grade serous carcinoma cases. Cytology alone demonstrated an overall accuracy of 71.88%, while p53 showed an accuracy of 73.79% and PAX-8 an accuracy of 69.90%. After combining all three methods through logistic regression analysis, specificity increased to 83.93%, positive predictive value to 78.05%, and overall accuracy to 76.60%. Following a sub-analysis focusing on high-grade serous carcinoma, cytology reached a sensitivity of 92.86%, while p53 and PAX-8 reached 82.14% and 78.57% respectively. The combination of cytology with PAX-8 further increased sensitivity to 100%.Conclusions The combination of tubal cytology and immunocytochemistry could be used as a reliable diagnostic tool for extrauterine high-grade serous carcinoma. Further evaluation of a larger sample size is warranted.
SN - 1471-2407
ER -